Aktis Oncology AKTS
NASDAQ AKTS
$16.62 +0.34 (+2.09%)
At close: Nov 13, 2026 · 4:00 PM EST

Aktis Oncology (AKTS) Non Operating Income (2025 - 2026)

Updated

Aktis Oncology's Non Operating Income was $4.81 million in Q3 2026, up 80.1% from $2.67 million a year earlier and up 1.1% from the prior quarter.

Analysis

Aktis Oncology (AKTS) Non Operating Income (2025 - 2026) Analysis & Trends

On a trailing twelve-month basis, Aktis Oncology's Non Operating Income was $16.18 million through Sep 30, 2026; for FY2025, it came in at $10.95 million, up 35.7% from FY2024.

  • In earlier years, Non Operating Income was $8.07 million in FY2024.
  • Compared with a year earlier, Non Operating Income has increased for three straight quarters.
  • Per Business Quant data, AKTS's Non Operating Income in the three quarters before Q3 2026 was $4.76 million (Q2 2026), $4.38 million (Q1 2026) and $2.24 million (Q4 2025).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) Non Op. Inc. (Qtr)
1 Eli Lilly 1,359.75 Bn 1,333.37 Bn 20.46 Bn -202.00 Mn
2 Johnson & Johnson 688.76 Bn 608.62 Bn 17.30 Bn -
3 AbbVie 521.69 Bn 489.75 Bn 13.12 Bn -
4 Merck 364.31 Bn 327.31 Bn 13.19 Bn -
5 Novartis Ag 306.35 Bn 279.93 Bn - -
6 Astrazeneca 285.96 Bn 259.56 Bn 13.26 Bn -
7 Amgen 251.88 Bn 203.53 Bn 7.58 Bn 1.63 Bn
8 Gilead Sciences 208.59 Bn 183.61 Bn 6.73 Bn -130.00 Mn
9 Pfizer 164.73 Bn 112.38 Bn 12.56 Bn -
10 Aktis Oncology 895.95 Mn 335.72 Mn - 4.81 Mn
Historic Data

Historic Data

Download Data
DateValue
Sep 30, 2026 4.81 Mn
Jun 30, 2026 4.76 Mn
Mar 31, 2026 4.38 Mn
Jun 30, 2025 2.89 Mn
Mar 31, 2025 3.16 Mn
API Access

Aktis Oncology Non Operating Income API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=non-operating-income&ticker=AKTS&period=max&api_key=YOUR_API_KEY